Guardant Health, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 16:18:59 10/06/2026 BST			5-day change	1st Jan Change
131.24 ^USD	+0.86%		+3.50%	+28.72%

06-09	Guardant Health Insider Sold Shares Worth $12,629,969, According to a Recent SEC Filing	MT
06-02	Evercore ISI Upgrades Guardant Health to Outperform From In Line, Adjusts PT to $160 From $95	MT

Published on 05/08/2026 at 02:31 am BST - Modified on 05/08/2026 at 10:05 am BST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good afternoon. Thank you for attending the Guardant Health Q1 2026 Earnings Call. My name is Matt, and I'll be the moderator for today's call.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

06-09	Guardant Health Insider Sold Shares Worth $12,629,969, According to a Recent SEC Filing	MT
06-02	Evercore ISI Upgrades Guardant Health to Outperform From In Line, Adjusts PT to $160 From $95	MT
05-29	Guardant Health Insider Sold Shares Worth $1,250,836, According to a Recent SEC Filing	MT
05-27	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Amid S&P 500, Nasdaq Rally, Middle East Peace Optimism	MT
05-27	Guardant Health Says Shield Blood Test Included in American Cancer Society Guidelines	MT
05-27	Guardant Health Shield Blood Test Included in Updated American Cancer Society Colorectal Cancer Screening Guidelines	CI
05-27	Blood test added to US colorectal cancer screening options	RE
05-26	Guardant Health Insider Sold Shares Worth $2,896,360, According to a Recent SEC Filing	MT
05-22	Guardant Health Insider Sold Shares Worth $735,049, According to a Recent SEC Filing	MT
05-22	Guardant Health Insider Sold Shares Worth $23,076,690, According to a Recent SEC Filing	MT
05-22	Guardant Health Insider Sold Shares Worth $2,130,229, According to a Recent SEC Filing	MT
05-20	Guardant Health Says US FDA Approved Liquid Biopsy Test	MT
05-20	Fda approves new Guardant360 liquid cdx, the largest FDA-approved liquid biopsy panel with a 100x expanded footprint	RE
05-20	Guardant Health Announces Fda Approval Of Guardant360 Liquid Cdx, The Largest Fda-Approved Liquid Biopsy Panel	CI
05-13	Guardant Health Insider Sold Shares Worth $5,016,000, According to a Recent SEC Filing	MT